Inhibition of human osteoblast growth by unfractionated heparin and by low molecular weight heparins in vitro

Thrombosis and Haemostasis

Volumn 88, Issue 2, 2002, Pages 361-362

  Kock, H J ^a   Handschin, Alexander E ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CERTOPARIN; CLEXANE 40; DALTEPARIN; ENOXAPARIN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; MONOEMBOLEX; NADROPARIN;

CELL COUNT; CELL CULTURE; CELL LEVEL; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; FLUORESCENCE ANALYSIS; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; LETTER; MODEL; OSTEOBLAST; PRIORITY JOURNAL;

EID: 0036335975     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613213     Document Type: Letter

References (11)

1. Heparin osteoporosis
2. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin
3. Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin in patients with venous thromboembolism and contraindications to coumarin
4. The effects of standard and low molecular weight heparin on bone nodule formation in vitro
5. Structural determinants of capacity of heparin to inhibit collagen synthesis in 21-day fetal rat calvaria
6. Human bone cells in vitro
7. Specific activity of skeletal alkaline phosphatase in human osteoblast-line cells regulated by phosphatase, phosphatase esters and phosphatase analogies and release of alkaline phosphatase activity inversely regulated by calcium
8. The effects of low molecular weight and standard heparin on calcium loss from fetal rat calvaria
9. Are the available low molecular weight heparin-preparations the same?
10. Hazards of heparin: Allergy, heparin-induced thrombocytopenia and osteoporosis
11. Osteoporosis and vertebral collapse following low-dose low molecular weight heparin therapy in a young patient